STX2 and atypical hemolytic-uremic syndrome: Differences in the capacity to regulate cytokine/chemokine expression during the course of the innate immune response, as well as differences in the ability to induce cell death may explain the greater potential of Stx2a to cause extra-intestinal complications such as D+HUS and CNS abnormalities, and fatality in humans.